Cengild Medical Berhad Total Liabilities
Cengild Medical Berhad total liabilities. Based on the latest financial reports, Cengild Medical Berhad (0243) has total liabilities worth RM103.97 Million MYR (≈ $26.10 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Cengild Medical Berhad liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Cengild Medical Berhad (2020–2026)
Total liabilities of Cengild Medical Berhad from 2020 to 2026. This chart illustrates how Cengild Medical Berhad's total liabilities have evolved over time, based on quarterly financial data.
Cengild Medical Berhad Competitors by Total Liabilities
The table below lists competitors of Cengild Medical Berhad ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wellbiotec Co. Ltd.
KO:010600
|
Korea | ₩11.76 Billion |
|
Kishin Corporation
KO:092440
|
Korea | ₩12.86 Billion |
|
Atlantaa Limited
NSE:ATLANTAA
|
India | Rs3.52 Billion |
|
Ai-Media Technologies Ltd
AU:AIM
|
Australia | AU$22.18 Million |
|
Tracxn Technologies Limited
NSE:TRACXN
|
India | Rs456.47 Million |
|
Adveritas Ltd
AU:AV1
|
Australia | AU$6.83 Million |
|
Willowglen MSC Bhd
KLSE:0008
|
Malaysia | RM41.05 Million |
|
Kartal Yenilenebilir Enerji Uretim AS
IS:KARYE
|
Turkey | TL931.18 Million |
Liability Composition Analysis (2020–2026)
This chart breaks down Cengild Medical Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cengild Medical Berhad balance sheet assets.
Liquidity & Leverage Metrics
Cengild Medical Berhad Total Liabilities Ratios Explained
Cengild Medical Berhad total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cengild Medical Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cengild Medical Berhad (2020–2026)
The table below shows the annual total liabilities of Cengild Medical Berhad from 2020 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | RM103.97 Million ≈ $26.10 Million |
+57.45% |
| 2025-06-30 | RM66.03 Million ≈ $16.58 Million |
+212.27% |
| 2024-06-30 | RM21.15 Million ≈ $5.31 Million |
-17.46% |
| 2023-06-30 | RM25.62 Million ≈ $6.43 Million |
-3.66% |
| 2022-06-30 | RM26.59 Million ≈ $6.68 Million |
-17.41% |
| 2021-06-30 | RM32.20 Million ≈ $8.08 Million |
-13.68% |
| 2020-06-30 | RM37.30 Million ≈ $9.37 Million |
-- |
About Cengild Medical Berhad
Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiolo… Read more